AN2 Therapeutics Director Joseph Zakrzewski Gifts 405,880 Shares

What Happened Joseph S. Zakrzewski, a director of AN2 Therapeutics (ANTX), reported a gift disposition of 405,880 shares on August 14, 2026. The filing shows the shares were disposed at $0.00 per share (total reported value $0), reflecting a transfer as a gift rather than a sale or purchase.

Key Details

• Transaction date: 2026-08-14; Transaction type/code: Gift (G).
• Shares transferred: 405,880 ANTX; Price per share reported: $0.00; total proceeds reported: $0.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes:
  • F1: The gift was to the Reporting Person’s children.
  • F2: The shares are (also) held by the "Nancy Zakrzewski TTEE Z3 Trust U/A DTD 11/25/14" (Z3 Trust); the reporting person disavows beneficial ownership of shares held by that trust.
• Filing timeliness: Reported for the same period/date (2026-08-14); no late-filing indicator noted.

Context Gifts are non-market transactions and do not necessarily indicate the insider’s view on the company's prospects. The filing documents a transfer to family members and references a trust holding; the disavowal of beneficial ownership for trust-held shares means those trust shares aren’t claimed as the insider’s personal beneficial holdings in this report.